AYTU
Price
$2.45
Change
-$0.08 (-3.16%)
Updated
Dec 26 closing price
Capitalization
25.78M
Intraday BUY SELL Signals
BHC
Price
$7.20
Change
+$0.02 (+0.28%)
Updated
Dec 26 closing price
Capitalization
2.66B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AYTU vs BHC

Header iconAYTU vs BHC Comparison
Open Charts AYTU vs BHCBanner chart's image
Aytu BioPharma
Price$2.45
Change-$0.08 (-3.16%)
Volume$66.52K
Capitalization25.78M
Bausch Health Companies
Price$7.20
Change+$0.02 (+0.28%)
Volume$1.02M
Capitalization2.66B
AYTU vs BHC Comparison Chart in %
View a ticker or compare two or three
VS
AYTU vs. BHC commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and BHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (AYTU: $2.45 vs. BHC: $7.20)
Brand notoriety: AYTU: Not notable vs. BHC: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 87% vs. BHC: 36%
Market capitalization -- AYTU: $24.96M vs. BHC: $2.66B
AYTU [@Pharmaceuticals: Generic] is valued at $24.96M. BHC’s [@Pharmaceuticals: Generic] market capitalization is $2.66B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whileBHC’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • BHC’s FA Score: 0 green, 5 red.
According to our system of comparison, AYTU is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 6 TA indicator(s) are bullish while BHC’s TA Score has 6 bullish TA indicator(s).

  • AYTU’s TA Score: 6 bullish, 4 bearish.
  • BHC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both AYTU and BHC are a good buy in the short-term.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -3.92% price change this week, while BHC (@Pharmaceuticals: Generic) price change was +4.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.01%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +23.01%.

Reported Earning Dates

BHC is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.01% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($2.66B) has a higher market cap than AYTU($25.8M). AYTU YTD gains are higher at: 48.824 vs. BHC (-10.918). BHC has higher annual earnings (EBITDA): 3.29B vs. AYTU (-5.21M). BHC has more cash in the bank: 1.31B vs. AYTU (32.6M). AYTU has less debt than BHC: AYTU (27.2M) vs BHC (21B). BHC has higher revenues than AYTU: BHC (10B) vs AYTU (63.7M).
AYTUBHCAYTU / BHC
Capitalization25.8M2.66B1%
EBITDA-5.21M3.29B-0%
Gain YTD48.824-10.918-447%
P/E RatioN/A7.40-
Revenue63.7M10B1%
Total Cash32.6M1.31B2%
Total Debt27.2M21B0%
FUNDAMENTALS RATINGS
AYTU vs BHC: Fundamental Ratings
AYTU
BHC
OUTLOOK RATING
1..100
4832
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3846
P/E GROWTH RATING
1..100
6598
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (38) in the Pharmaceuticals Other industry is in the same range as AYTU (46) in the Other Consumer Services industry. This means that BHC’s stock grew similarly to AYTU’s over the last 12 months.

BHC's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as AYTU (100) in the Other Consumer Services industry. This means that BHC’s stock grew similarly to AYTU’s over the last 12 months.

AYTU's SMR Rating (97) in the Other Consumer Services industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to BHC’s over the last 12 months.

AYTU's Price Growth Rating (38) in the Other Consumer Services industry is in the same range as BHC (46) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to BHC’s over the last 12 months.

AYTU's P/E Growth Rating (65) in the Other Consumer Services industry is somewhat better than the same rating for BHC (98) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUBHC
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
64%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 5 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 13 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signal:
Gain/Loss:
BHC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JERIX12.160.06
+0.50%
Janus Henderson Global Real Estate I
GAOSX21.390.04
+0.19%
JPMorgan Global Allocation I
CGVYX28.440.03
+0.11%
American Funds Global Insight 529-A
MREGX15.840.01
+0.06%
BlackRock Unconstrained Equity R
VALAX29.51N/A
N/A
Al Frank Adv

AYTU and

Correlation & Price change

A.I.dvisor tells us that AYTU and AMPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-0.39%
AMPH - AYTU
29%
Poorly correlated
+1.36%
TRUFF - AYTU
22%
Poorly correlated
-6.21%
ETON - AYTU
21%
Poorly correlated
+2.66%
IMCC - AYTU
21%
Poorly correlated
+0.68%
PBH - AYTU
21%
Poorly correlated
+0.18%
More

BHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHC has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
-1.91%
AMRX - BHC
39%
Loosely correlated
+0.23%
VTRS - BHC
36%
Loosely correlated
+1.83%
AMPH - BHC
35%
Loosely correlated
+1.36%
HROW - BHC
27%
Poorly correlated
+2.05%
TEVA - BHC
26%
Poorly correlated
+0.63%
More